USPTO serial 86715608
B-PS BIO-PHARM SOLUTIONS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- FROMM, MARTHA L
- Law office
- TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with B-PS BIO-PHARM SOLUTIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Emily Miao
EMILY MIAO McDonnell Boehnen Hulbert & Berghoff Llp300 S Wacker Dr Ste 3100Chicago, IL 60606-6706UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of epileptic, multiple sclerosis, Lou Gerig's disease, Alzheimer's and nerve disorder; Pharmaceutical preparations for treating diabetes; Pharmaceutical agents affecting metabolism; Headache treatment preparations; Pharmaceutical preparations for peripheral nervous system; Pharmaceuticals for the treatment of erectile dysfunction; Medicines for alleviating constipation; Anti-inflammatory preparations; Anti-inflammatory and antipyretic preparations; Appetite suppressant pills; Nervines, namely, nerve calming preparations for medical purposes; Pharmaceutical preparations for ocular or intraocular surgery; Eye drops; Capsules sold empty for medicines; Syrups for pharmaceutical purposes for the treatment of epileptic, multiple sclerosis, Lou Gerig's disease, Alzheimer's and nerve disorder; Non-medicated lozenges; Medicated lozenges; Cachets for pharmaceutical purposes; Medicaments promoting recovery from epileptic, multiple sclerosis, Lou Gerig's disease, Alzheimer's and nerve disorder; Chemico-pharmaceutical preparations for the prevention of epileptic, multiple sclerosis, Lou Gerig's disease, Alzheimer's and nerve disorder; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Medical preparations for the treatment of epileptic, multiple sclerosis, Lou Gerig's disease, Alzheimer's and nerve disorder; Pharmaceutical preparations for tumor treatment; Pharmaceutical preparations for central nervous system; Pharmaceutical preparations for central nerve treatment; Sedatives; Analgesics; Medical preparations for slimming purposes; Slimming pills; Anti-diabetic pharmaceuticals; Antibiotics; Anti-cancer preparations; Antidepressants; Tumor suppressing agents; Antipyretic analgesics; Febrifuges; Hypoglycemic agents | ACTIVE | — |
| 042 | Conducting scientific feasibility studies; Technical research in the field of drug development, pharmacy, central nervous system(CNS); Research and development of new products for others; Testing, inspection or research of pharmaceuticals, cosmetics and foodstuff; Research and development of vaccines and medicines; Research on adult diseases; Research on cancer; Pharmaceutical products development; Pharmaceutical products research; Pharmaceutical products evaluation; Consultancy pertaining to pharmacology; Medical product testing; Research for medical products; Medical research; Clinical trials; Biotechnology research; Biological research; Biochemical research; Chemical research and analysis; Chemical research; Testing of raw materials; Product safety testing; Product evaluation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 15, 2016 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 15, 2016 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 1, 2015 | UNDC | UNDELIVERABLE MAIL - COURTESY COPY MAILED | — |
| Nov 28, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2015 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 10, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2015 | NWAP | NEW APPLICATION ENTERED | — |